Boston Trust Walden Corp Danaher Corp Transaction History

Boston Trust Walden Corp

$14.1 Billion
Q3 2024

A detailed history of Boston Trust Walden Corp transactions in Danaher Corp stock. As of the latest transaction made, Boston Trust Walden Corp holds 45,389 shares of DHR stock, worth $11 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

45,389

Previous 46,068 1.47%

Holding current value

$11 Million

Previous $11.5 Million 9.62%

% of portfolio

0.09%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$239.25 - $280.76 $162,450 - $190,636	-679 Reduced 1.47%	45,389 $12.6 Million
Q2 2024 Jul 19, 2024	SELL	$235.51 - $267.98 $136,124 - $154,892	-578 Reduced 1.24%	46,068 $11.5 Million
Q1 2024 Apr 22, 2024	SELL	$224.58 - $256.19 $36,606 - $41,758	-163 Reduced 0.35%	46,646 $11.6 Million
Q4 2023 Jan 24, 2024	SELL	$185.1 - $233.13 $97,732 - $123,092	-528 Reduced 1.12%	46,809 $10.8 Million
Q3 2023 Oct 18, 2023	SELL	$233.08 - $265.59 $115,840 - $131,998	-497 Reduced 1.04%	47,337 $11.7 Million
Q2 2023 Jul 24, 2023	SELL	$224.99 - $256.14 $100,570 - $114,494	-447 Reduced 0.93%	47,834 $11.5 Million
Q1 2023 Apr 19, 2023	SELL	$239.75 - $277.0 $1.46 Million - $1.69 Million	-6,095 Reduced 11.21%	48,281 $12.2 Million
Q4 2022 Jan 20, 2023	BUY	$241.42 - $282.29 $5,794 - $6,774	24 Added 0.04%	54,376 $0
Q3 2022 Oct 19, 2022	SELL	$247.06 - $1507.4 $255,707 - $1.56 Million	-1,035 Reduced 1.87%	54,352 $14 Million
Q2 2022 Jul 22, 2022	BUY	$237.11 - $299.66 $121,163 - $153,126	511 Added 0.93%	55,387 $14 Million
Q1 2022 Apr 20, 2022	SELL	$257.27 - $315.76 $2.39 Million - $2.94 Million	-9,306 Reduced 14.5%	54,876 $16.1 Million
Q4 2021 Jan 21, 2022	SELL	$292.08 - $329.01 $445,129 - $501,411	-1,524 Reduced 2.32%	64,182 $21.1 Million
Q3 2021 Oct 25, 2021	BUY	$272.21 - $332.43 $160,603 - $196,133	590 Added 0.91%	65,706 $20 Million
Q2 2021 Jul 22, 2021	SELL	$225.08 - $271.69 $239,710 - $289,349	-1,065 Reduced 1.61%	65,116 $17.5 Million
Q1 2021 Apr 21, 2021	SELL	$212.38 - $245.9 $542,206 - $627,782	-2,553 Reduced 3.71%	66,181 $14.9 Million
Q4 2020 Jan 15, 2021	SELL	$212.5 - $245.46 $845,750 - $976,930	-3,980 Reduced 5.47%	68,734 $15.3 Million
Q3 2020 Oct 14, 2020	SELL	$177.16 - $215.33 $4.64 Million - $5.64 Million	-26,178 Reduced 26.47%	72,714 $15.7 Million
Q2 2020 Jul 23, 2020	SELL	$128.7 - $176.83 $14.6 Million - $20.1 Million	-113,651 Reduced 53.47%	98,892 $17.5 Million
Q1 2020 Apr 21, 2020	SELL	$121.39 - $169.05 $5 Million - $6.96 Million	-41,180 Reduced 16.23%	212,543 $29.4 Million
Q4 2019 Jan 10, 2020	SELL	$133.47 - $153.48 $17,751 - $20,412	-133 Reduced 0.05%	253,723 $38.9 Million
Q3 2019 Oct 21, 2019	SELL	$135.4 - $146.47 $1 Million - $1.08 Million	-7,405 Reduced 2.83%	253,856 $36.7 Million
Q2 2019 Jul 25, 2019	BUY	$124.88 - $143.73 $306,205 - $352,425	2,452 Added 0.95%	261,261 $37.3 Million
Q1 2019 Apr 16, 2019	BUY	$97.62 - $132.29 $943,594 - $1.28 Million	9,666 Added 3.88%	258,809 $34.2 Million
Q4 2018 Jan 17, 2019	BUY	$94.85 - $109.54 $12,330 - $14,240	130 Added 0.05%	249,143 $25.7 Million
Q3 2018 Oct 23, 2018	BUY	$98.13 - $108.9 $73,204 - $81,239	746 Added 0.3%	249,013 $27.1 Million
Q2 2018 Jul 25, 2018	SELL	$96.1 - $103.24 $778,602 - $836,450	-8,102 Reduced 3.16%	248,267 $24.5 Million
Q1 2018 Apr 13, 2018	BUY	$92.16 - $103.8 $419,973 - $473,016	4,557 Added 1.81%	256,369 $25.1 Million
Q4 2017 Jan 29, 2018	BUY	$85.26 - $94.62 $1.42 Million - $1.58 Million	16,710 Added 7.11%	251,812 $23.4 Million
Q3 2017 Oct 13, 2017	BUY	$79.29 - $88.45 $18.6 Million - $20.8 Million	235,102	235,102 $20.2 Million

Others Institutions Holding DHR

# of Institutions

2,432

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.11M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account

Boston Trust Walden Corp Danaher Corp Transaction History